NEW YORK (GenomeWeb) – Luminex reported after the close of the market on Monday that its fourth quarter revenues rose 4 percent year over year, in line with preliminary estimates.

For the three months ended Dec. 31, 2018, the firm said revenues rose to $81.1 million from $78.2 million a year ago, beating the analysts' consensus estimate of $79.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.